TITLE

LETTERS TO THE EDITORS

AUTHOR(S)
Read, Sandra; Sterlini, Alber
PUB. DATE
May 2009
SOURCE
Hill;5/12/2009, Vol. 16 Issue 53, p22
SOURCE TYPE
Newspaper
DOC. TYPE
Letter
ABSTRACT
Several letters to the editor are presented in response to articles in previous issues including "Obama budget nixes aid for jailing illegal immigrants," and one discussing the failure of the Food and Drug Administration (FDA) to approve comprehensive ingredients that would prevent skin cancer.
ACCESSION #
40643654

 

Related Articles

  • What Is the Role of the FDA Consumer Safety Officer?  // Applied Clinical Trials;Jan2010, Vol. 19 Issue 1, p14 

    A letter to the editor is presented in response to an article about the role of the U.S. Food and Drug Administration (FDA) Consumer Safety Officer in the previous issue.

  • FDA's drug and e-cigarette warnings counterproductive. Stier, Jeff; Beavers, Shyron M. // Hill;9/15/2009, Vol. 16 Issue 102, p28 

    Two letters to the editor are presented in response to articles in previous issues, such as one on the Food and Drug Administration's (FDA) warnings on drugs that treat Crohn's disease and colitis and e-cigarettes, a product used to quit smoking real cigarettes, in 2009.

  • No jake-legged reformers. Johnson, Greg // H&HN: Hospitals & Health Networks;Sep2007, Vol. 81 Issue 9, p8 

    A letter to the editor is presented in response to the article "Happy Tails, Jake Leg and the Food and Drug Administration" published online on August 7, 2007.

  • Letter to the Editor. Kelly, Tom L. // Medical Design Technology;Feb2005, Vol. 9 Issue 2, p9 

    Presents a letter to the editor about the policy at the U.S. Food and Drug Administration.

  • What Ails the FDA? Gorelick, Kenneth J. // New England Journal of Medicine;6/16/2005, Vol. 352 Issue 24, p2553 

    A letter to the editor is presented in response to an article on what ails the U.S. Food and Drug Administration (FDA) by researcher S. Okie in the March 17, 2005 issue.

  • What Ails the FDA? Marcus, Donald M. // New England Journal of Medicine;6/16/2005, Vol. 352 Issue 24, p2553 

    A letter to the editor is presented in response to an article on what ails the U.S. Food and Drug Administration (FDA) by researcher S. Okie in the March 17, 2005 issue.

  • What Ails the FDA? Cohen, Fredric J. // New England Journal of Medicine;6/16/2005, Vol. 352 Issue 24, p2553 

    A letter to the editor is presented in response to an article on what ails the U.S. Food and Drug Administration (FDA) by researcher S. Okie in the March 17, 2005 issue.

  • What Ails the FDA? Jenny-Avital, Elizabeth R. // New England Journal of Medicine;6/16/2005, Vol. 352 Issue 24, p2553 

    A letter to the editor is presented on the institutionalized influence of the U.S. pharmaceutical industry on the U.S. Food and Drug Administration (FDA).

  • More on Fluoroquinolone Antibiotics and Tendon Rupture. Szarfman, Ana; Chen, Min; Blum, Michael D. // New England Journal of Medicine;1/19/95, Vol. 332 Issue 3, p193 

    A letter to the editor is presented in response to an article on fluoroquinolone antibiotics and tendon rupture in the September 15 1995 issue, which presents information from the Food & Drug Administration's Postmarketing Spontaneous Reporting System.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics